Condition
Childhood Leukemia, Acute Lymphoblastic clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Childhood Leukemia, Acute Lymphoblastic clinical trials that are recruiting, at sites in 2 countries (most in China (4), Hong Kong (4)). By phase: Phase 2/3 (3), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 2Countries
Newest Childhood Leukemia, Acute Lymphoblastic clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Treatment plan for newly diagnosed pediatric Philadelphia chromosome–positive B‑cell acute lymphoblastic leukemia | Phase 3 | Hefei, Anhui and 23 other locations | Recruiting | Sep 3, 2025 |
| Newly diagnosed low‑risk pediatric B‑cell ALL treatment with short blinatumomab courses | Phase 2/3 | Hefei, Anhui and 26 other locations | Recruiting | Mar 18, 2025 |
| New treatment approach for children newly diagnosed with T‑cell acute lymphoblastic leukemia using dasatinib, venetoclax, and homoharringtonine | Phase 2/3 | Hefei, Anhui and 26 other locations | Recruiting | Mar 4, 2025 |
| New treatment options for children with high-risk B-cell leukemia | Phase 2/3 | Hefei, Anhui and 26 other locations | Recruiting | Jan 8, 2025 |
All recruiting trials (4)
-
Treatment plan for newly diagnosed pediatric Philadelphia chromosome–positive B‑cell acute lymphoblastic leukemia
This Phase 3 effort tests a chemotherapy‑light approach using olverembatinib together with blinatumomab and intermittent venetoclax to see if children and adolescents newly diagnosed with Ph+ B‑ALL can be cured with less toxicity.
-
Newly diagnosed low‑risk pediatric B‑cell ALL treatment with short blinatumomab courses
This protocol will try giving two short 14‑day courses of blinatumomab early and during consolidation for children with newly diagnosed low‑risk B‑cell ALL to allow less intensive later chemotherapy when deep MRD negativity is achieved.
-
New treatment approach for children newly diagnosed with T‑cell acute lymphoblastic leukemia using dasatinib, venetoclax, and homoharringtonine
This study will try adding dasatinib, venetoclax, and homoharringtonine to standard chemotherapy for children and adolescents newly diagnosed with T‑cell acute lymphoblastic leukemia to see if it increases deep (MRD‑negative) remissions and lowers relapse.
-
New treatment options for children with high-risk B-cell leukemia
This study is testing two different treatment options for children with high-risk B-cell leukemia to see which one helps them get better and live longer.
Related topics
Quick answers
How many Childhood Leukemia, Acute Lymphoblastic clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in China (4 trials), Hong Kong (4 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2/3: 3, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.